SlideShare a Scribd company logo

Magic therapeutic antibody discovery platform flyer

•
•
Creative Biolabs
Creative Biolabs

A novel Magic™ Therapeutic Antibody Discovery Platform (MTADP) for high throughput antibody identification which integrates phage display, novel single DNA isolation technology and next generation sequencing (NGS) technology.

Technology
1 of 1
Download to read offline
MagicTM Therapeutic Antibody Discovery Platform Creative Biolabs has developed a novel Magic™ Therapeutic Antibody Discovery Platform (MTADP) for high- throughput antibody identification which integrates phage display, novel single DNA isolation technology and next generation sequencing (NGS) technology. MTADP Technology Advantages of Therapeutic Antibody Discovery at Creative Biolabs Full Length VH-VL linkage analysis (Read length>1,000 bp) Large numbers of candidate clones with high affinity and specificity Novel single DNA identification Multiple clonal ID tag Accurate NGS-based antibody sequencing Low cost and time-saving Retrieval of the physical DNA for further characterization Phage Display Antibody Library Analysis Sample Report (partial) Contact Us Email: info@creative-biolabs.com Web: www.creative-biolabs.com Tel: 1-631-381-2994 Fax: 1-631-207-8356 Address: 45-1 Ramsey Road, Shirley, NY 11967, USA

Recommended

Use of Next Generation Sequencing techniques for characterisation of baculovi...
Use of Next Generation Sequencing techniques for characterisation of baculovi...Use of Next Generation Sequencing techniques for characterisation of baculovi...
Use of Next Generation Sequencing techniques for characterisation of baculovi...
OECD Environment
 
Improving exome sequencing, targeted sequencing, and low frequency variant de...
Improving exome sequencing, targeted sequencing, and low frequency variant de...Improving exome sequencing, targeted sequencing, and low frequency variant de...
Improving exome sequencing, targeted sequencing, and low frequency variant de...
Laura Berry
 
Activities in development of bioinformatics pipelines for characterisation of...
Activities in development of bioinformatics pipelines for characterisation of...Activities in development of bioinformatics pipelines for characterisation of...
Activities in development of bioinformatics pipelines for characterisation of...
OECD Environment
 
Analyzing the exome—focusing your NGS analysis with high performance target c...
Analyzing the exome—focusing your NGS analysis with high performance target c...Analyzing the exome—focusing your NGS analysis with high performance target c...
Analyzing the exome—focusing your NGS analysis with high performance target c...
Integrated DNA Technologies
 
Poster ESHG
Poster ESHGPoster ESHG
Poster ESHG
Kirsten van Nimwegen
 
Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17
Matthew Holguin
 
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Nathan Olson
 
Session 3: Application of next-generation sequencing to routine plant virus d...
Session 3: Application of next-generation sequencing to routine plant virus d...Session 3: Application of next-generation sequencing to routine plant virus d...
Session 3: Application of next-generation sequencing to routine plant virus d...
Plant Biosecurity Cooperative Research Centre
 

Recommended

Use of Next Generation Sequencing techniques for characterisation of baculovi...
Use of Next Generation Sequencing techniques for characterisation of baculovi...Use of Next Generation Sequencing techniques for characterisation of baculovi...
Use of Next Generation Sequencing techniques for characterisation of baculovi...
OECD Environment
 
Improving exome sequencing, targeted sequencing, and low frequency variant de...
Improving exome sequencing, targeted sequencing, and low frequency variant de...Improving exome sequencing, targeted sequencing, and low frequency variant de...
Improving exome sequencing, targeted sequencing, and low frequency variant de...
Laura Berry
 
Activities in development of bioinformatics pipelines for characterisation of...
Activities in development of bioinformatics pipelines for characterisation of...Activities in development of bioinformatics pipelines for characterisation of...
Activities in development of bioinformatics pipelines for characterisation of...
OECD Environment
 
Analyzing the exome—focusing your NGS analysis with high performance target c...
Analyzing the exome—focusing your NGS analysis with high performance target c...Analyzing the exome—focusing your NGS analysis with high performance target c...
Analyzing the exome—focusing your NGS analysis with high performance target c...
Integrated DNA Technologies
 
Poster ESHG
Poster ESHGPoster ESHG
Poster ESHG
Kirsten van Nimwegen
 
Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17
Matthew Holguin
 
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Nathan Olson
 
Session 3: Application of next-generation sequencing to routine plant virus d...
Session 3: Application of next-generation sequencing to routine plant virus d...Session 3: Application of next-generation sequencing to routine plant virus d...
Session 3: Application of next-generation sequencing to routine plant virus d...
Plant Biosecurity Cooperative Research Centre
 
VS-CNV Annotations from the User's Perspective
VS-CNV Annotations from the User's PerspectiveVS-CNV Annotations from the User's Perspective
VS-CNV Annotations from the User's Perspective
Golden Helix
 
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
Deepak Balaji T G
 
Achieve improved variant detection in single cell sequencing infographic
Achieve improved variant detection in single cell sequencing infographicAchieve improved variant detection in single cell sequencing infographic
Achieve improved variant detection in single cell sequencing infographic
QIAGEN
 
High-Throughput Sequencing
High-Throughput SequencingHigh-Throughput Sequencing
High-Throughput Sequencing
Mark Pallen
 
Aug2015 deanna church analytical validation
Aug2015 deanna church analytical validationAug2015 deanna church analytical validation
Aug2015 deanna church analytical validation
GenomeInABottle
 
Bioinformatics as a tool for understanding clinically significant variations ...
Bioinformatics as a tool for understanding clinically significant variations ...Bioinformatics as a tool for understanding clinically significant variations ...
Bioinformatics as a tool for understanding clinically significant variations ...
Despoina Kalfakakou
 
2012 10-24 - ngs webinar
2012 10-24 - ngs webinar2012 10-24 - ngs webinar
2012 10-24 - ngs webinar
Elsa von Licy
 
NGS: bioinformatic challenges
NGS: bioinformatic challengesNGS: bioinformatic challenges
NGS: bioinformatic challenges
Lex Nederbragt
 
Ngs webinar 2013
Ngs webinar 2013Ngs webinar 2013
Ngs webinar 2013
Elsa von Licy
 
The relative ease of use and reproducibility of
The relative ease of use and reproducibility ofThe relative ease of use and reproducibility of
The relative ease of use and reproducibility of
Shiv Nadar University
 
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
ExternalEvents
 
2013 02-14 - ngs webinar - sellappan
2013 02-14 - ngs webinar - sellappan2013 02-14 - ngs webinar - sellappan
2013 02-14 - ngs webinar - sellappan
Elsa von Licy
 
Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...
Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...
Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...
VHIR Vall d’Hebron Institut de Recerca
 
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
John Blue
 
Sophie F. summer Poster Final
Sophie F. summer Poster FinalSophie F. summer Poster Final
Sophie F. summer Poster Final
Sophie Friedheim
 
Session 6: New tools for field grains surveillance
Session 6: New tools for field grains surveillanceSession 6: New tools for field grains surveillance
Session 6: New tools for field grains surveillance
Plant Biosecurity Cooperative Research Centre
 
David Cooke wp1 14 Nov 19
David Cooke wp1 14 Nov 19David Cooke wp1 14 Nov 19
David Cooke wp1 14 Nov 19
Forest Research
 
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysisBioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
Despoina Kalfakakou
 
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
Candy Smellie
 
Understanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assaysUnderstanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assays
Candy Smellie
 
Practical semantics in the pharmaceutical industry - the Open PHACTS project
Practical semantics in the pharmaceutical industry - the Open PHACTS projectPractical semantics in the pharmaceutical industry - the Open PHACTS project
Practical semantics in the pharmaceutical industry - the Open PHACTS project
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Slas2012 Whoeck
Slas2012 WhoeckSlas2012 Whoeck
Slas2012 Whoeck
Wolfgang G. Hoeck
 

More Related Content

What's hot

EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
Deepak Balaji T G
 
2012 10-24 - ngs webinar
2012 10-24 - ngs webinar2012 10-24 - ngs webinar
2012 10-24 - ngs webinar
Elsa von Licy
 
2013 02-14 - ngs webinar - sellappan
2013 02-14 - ngs webinar - sellappan2013 02-14 - ngs webinar - sellappan
2013 02-14 - ngs webinar - sellappan
Elsa von Licy
 
Sophie F. summer Poster Final
Sophie F. summer Poster FinalSophie F. summer Poster Final
Sophie F. summer Poster Final
Sophie Friedheim
 
Understanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assaysUnderstanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assays
Candy Smellie
 

What's hot (20)

VS-CNV Annotations from the User's Perspective
VS-CNV Annotations from the User's PerspectiveVS-CNV Annotations from the User's Perspective
VS-CNV Annotations from the User's Perspective
 
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Bio...
 
Achieve improved variant detection in single cell sequencing infographic
Achieve improved variant detection in single cell sequencing infographicAchieve improved variant detection in single cell sequencing infographic
Achieve improved variant detection in single cell sequencing infographic
 
High-Throughput Sequencing
High-Throughput SequencingHigh-Throughput Sequencing
High-Throughput Sequencing
 
Aug2015 deanna church analytical validation
Aug2015 deanna church analytical validationAug2015 deanna church analytical validation
Aug2015 deanna church analytical validation
 
Bioinformatics as a tool for understanding clinically significant variations ...
Bioinformatics as a tool for understanding clinically significant variations ...Bioinformatics as a tool for understanding clinically significant variations ...
Bioinformatics as a tool for understanding clinically significant variations ...
 
2012 10-24 - ngs webinar
2012 10-24 - ngs webinar2012 10-24 - ngs webinar
2012 10-24 - ngs webinar
 
NGS: bioinformatic challenges
NGS: bioinformatic challengesNGS: bioinformatic challenges
NGS: bioinformatic challenges
 
Ngs webinar 2013
Ngs webinar 2013Ngs webinar 2013
Ngs webinar 2013
 
The relative ease of use and reproducibility of
The relative ease of use and reproducibility ofThe relative ease of use and reproducibility of
The relative ease of use and reproducibility of
 
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
 
2013 02-14 - ngs webinar - sellappan
2013 02-14 - ngs webinar - sellappan2013 02-14 - ngs webinar - sellappan
2013 02-14 - ngs webinar - sellappan
 
Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...
Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...
Introduction to NGS Variant Calling Analysis (UEB-UAT Bioinformatics Course -...
 
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
 
Sophie F. summer Poster Final
Sophie F. summer Poster FinalSophie F. summer Poster Final
Sophie F. summer Poster Final
 
Session 6: New tools for field grains surveillance
Session 6: New tools for field grains surveillanceSession 6: New tools for field grains surveillance
Session 6: New tools for field grains surveillance
 
David Cooke wp1 14 Nov 19
David Cooke wp1 14 Nov 19David Cooke wp1 14 Nov 19
David Cooke wp1 14 Nov 19
 
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysisBioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
 
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
 
Understanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assaysUnderstanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assays
 

Similar to Magic therapeutic antibody discovery platform flyer

Practical semantics in the pharmaceutical industry - the Open PHACTS project
Practical semantics in the pharmaceutical industry - the Open PHACTS projectPractical semantics in the pharmaceutical industry - the Open PHACTS project
Practical semantics in the pharmaceutical industry - the Open PHACTS project
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Next generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic TechnologyNext generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic Technology
Genotypic Technology
 
Analyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingAnalyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation Sequencing
QIAGEN
 
Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...
Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...
Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...
Golden Helix
 
Nomotech short eng
Nomotech short engNomotech short eng
Nomotech short eng
max_pavlenko
 

Similar to Magic therapeutic antibody discovery platform flyer (20)

Practical semantics in the pharmaceutical industry - the Open PHACTS project
Practical semantics in the pharmaceutical industry - the Open PHACTS projectPractical semantics in the pharmaceutical industry - the Open PHACTS project
Practical semantics in the pharmaceutical industry - the Open PHACTS project
 
Slas2012 Whoeck
Slas2012 WhoeckSlas2012 Whoeck
Slas2012 Whoeck
 
Opening up pharmacological space, the OPEN PHACTs api
Opening up pharmacological space, the OPEN PHACTs apiOpening up pharmacological space, the OPEN PHACTs api
Opening up pharmacological space, the OPEN PHACTs api
 
One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBio
 
Viral genome sequencing
Viral genome sequencingViral genome sequencing
Viral genome sequencing
 
sdAb Screening Services
sdAb Screening ServicessdAb Screening Services
sdAb Screening Services
 
Next generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic TechnologyNext generation sequencing & microarray-- Genotypic Technology
Next generation sequencing & microarray-- Genotypic Technology
 
Axt microarrays
Axt microarraysAxt microarrays
Axt microarrays
 
sdAb Functional Identification
sdAb Functional IdentificationsdAb Functional Identification
sdAb Functional Identification
 
Sdab discovery
Sdab discoverySdab discovery
Sdab discovery
 
Phage Display Screening for Single Domain Antibody (sdAb)
Phage Display Screening for Single Domain Antibody (sdAb)Phage Display Screening for Single Domain Antibody (sdAb)
Phage Display Screening for Single Domain Antibody (sdAb)
 
Ngs part ii 2013
Ngs part ii 2013Ngs part ii 2013
Ngs part ii 2013
 
Analyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingAnalyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation Sequencing
 
Analytical testing services
Analytical testing servicesAnalytical testing services
Analytical testing services
 
Ngs part i 2013
Ngs part i 2013Ngs part i 2013
Ngs part i 2013
 
Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...
Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...
Analyzing Performance of the Twist Exome with CNV Backbone at Various Probe D...
 
Exploring new frontiers with next-generation sequencing
Exploring new frontiers with next-generation sequencingExploring new frontiers with next-generation sequencing
Exploring new frontiers with next-generation sequencing
 
Giab for jax long read 190917
Giab for jax long read 190917Giab for jax long read 190917
Giab for jax long read 190917
 
Nomotech short eng
Nomotech short engNomotech short eng
Nomotech short eng
 
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
 

More from Creative Biolabs

More from Creative Biolabs (20)

What is oncolytic virus
What is oncolytic virusWhat is oncolytic virus
What is oncolytic virus
 
What is oncolytic virus therapy
What is oncolytic virus therapyWhat is oncolytic virus therapy
What is oncolytic virus therapy
 
Reporter-encoding Oncolytic Virus
Reporter-encoding Oncolytic VirusReporter-encoding Oncolytic Virus
Reporter-encoding Oncolytic Virus
 
Pre-made Oncolytic VACV
Pre-made Oncolytic VACVPre-made Oncolytic VACV
Pre-made Oncolytic VACV
 
Pre-made Oncolytic Vaccinia Virus
Pre-made Oncolytic Vaccinia VirusPre-made Oncolytic Vaccinia Virus
Pre-made Oncolytic Vaccinia Virus
 
Pre-made Oncolytic HSV
Pre-made Oncolytic HSVPre-made Oncolytic HSV
Pre-made Oncolytic HSV
 
Pre-made Oncolytic Herpes Simplex Virus
Pre-made Oncolytic Herpes Simplex VirusPre-made Oncolytic Herpes Simplex Virus
Pre-made Oncolytic Herpes Simplex Virus
 
Oncolytic Virus Delivery
Oncolytic Virus DeliveryOncolytic Virus Delivery
Oncolytic Virus Delivery
 
Oncolytic Virus Application
Oncolytic Virus ApplicationOncolytic Virus Application
Oncolytic Virus Application
 
Oncolytic Virus Animal Model
Oncolytic Virus Animal ModelOncolytic Virus Animal Model
Oncolytic Virus Animal Model
 
Abciximab mechanism of action
Abciximab mechanism of actionAbciximab mechanism of action
Abciximab mechanism of action
 
Abagovomab mechanism of action
Abagovomab mechanism of actionAbagovomab mechanism of action
Abagovomab mechanism of action
 
Wnt Pathway
Wnt PathwayWnt Pathway
Wnt Pathway
 
TNF Pathway
TNF PathwayTNF Pathway
TNF Pathway
 
TLR Pathway
TLR PathwayTLR Pathway
TLR Pathway
 
TGF-β Pathway
TGF-β PathwayTGF-β Pathway
TGF-β Pathway
 
TCR Pathway
TCR PathwayTCR Pathway
TCR Pathway
 
RAS Pathway
RAS PathwayRAS Pathway
RAS Pathway
 
PPAR Pathway
PPAR PathwayPPAR Pathway
PPAR Pathway
 
VPI3K-AKT Pathway
VPI3K-AKT PathwayVPI3K-AKT Pathway
VPI3K-AKT Pathway
 

Recently uploaded

Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
panagenda
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
Safe Software
 
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live StreamsTop 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
Roshan Dwivedi
 
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Principled Technologies
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
sammart93
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
Joaquim Jorge
 

Recently uploaded (20)

🐬 The future of MySQL is Postgres 🐘
🐬 The future of MySQL is Postgres 🐘🐬 The future of MySQL is Postgres 🐘
🐬 The future of MySQL is Postgres 🐘
 
Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live StreamsTop 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 

Magic therapeutic antibody discovery platform flyer

  • 1. MagicTM Therapeutic Antibody Discovery Platform Creative Biolabs has developed a novel Magic™ Therapeutic Antibody Discovery Platform (MTADP) for high- throughput antibody identification which integrates phage display, novel single DNA isolation technology and next generation sequencing (NGS) technology. MTADP Technology Advantages of Therapeutic Antibody Discovery at Creative Biolabs Full Length VH-VL linkage analysis (Read length>1,000 bp) Large numbers of candidate clones with high affinity and specificity Novel single DNA identification Multiple clonal ID tag Accurate NGS-based antibody sequencing Low cost and time-saving Retrieval of the physical DNA for further characterization Phage Display Antibody Library Analysis Sample Report (partial) Contact Us Email: info@creative-biolabs.com Web: www.creative-biolabs.com Tel: 1-631-381-2994 Fax: 1-631-207-8356 Address: 45-1 Ramsey Road, Shirley, NY 11967, USA